M R Hayden|M M Nelson - JoVE Visualize

Showing results (311-320 of 333) with videos related to

Pageof 34

Sort By:

Atherosclerosis|December 4, 2003

Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle sizeJ A Kuivenhoven, G K Hovingh, A van Tol, et al.

Human Molecular Genetics|February 1, 1997

Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analysesS S Chong, E Almqvist, H Telenius, et al.

The American Journal of Clinical Nutrition|March 1, 1987

Body composition of Peruvian children with short stature and high weight-for-height. I. Total body-water measurements and their prediction from anthropometric valuesT W Boutton, F L Trowbridge, M M Nelson, et al.

Circulation|March 10, 2001

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery diseaseS M Clee, A H Zwinderman, J C Engert, et al.

Pediatric Blood & Cancer|February 27, 2013

Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in childrenH Visscher, C J D Ross, S R Rassekh, et al.

The Journal of Biological Chemistry|June 26, 2001

Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1R R Singaraja, V Bocher, E R James, et al.

The Journal of Clinical Investigation|November 22, 2000

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotesS M Clee, J J Kastelein, M van Dam, et al.

Neuron|July 13, 1999

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegenerationJ G Hodgson, N Agopyan, C A Gutekunst, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997

Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase geneE Ehrenborg, S M Clee, S N Pimstone, et al.

Cell Death and Differentiation|January 10, 2004

Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's diseaseE Hermel, J Gafni, S S Propp, et al.

Pageof 34

Showing results (311-320 of 333) with videos related to

Sort By:

Pageof 34

Atherosclerosis|December 4, 2003

Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle sizeJ A Kuivenhoven, G K Hovingh, A van Tol, et al.

Human Molecular Genetics|February 1, 1997

Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analysesS S Chong, E Almqvist, H Telenius, et al.

The American Journal of Clinical Nutrition|March 1, 1987

Body composition of Peruvian children with short stature and high weight-for-height. I. Total body-water measurements and their prediction from anthropometric valuesT W Boutton, F L Trowbridge, M M Nelson, et al.

Circulation|March 10, 2001

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery diseaseS M Clee, A H Zwinderman, J C Engert, et al.

Pediatric Blood & Cancer|February 27, 2013

Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in childrenH Visscher, C J D Ross, S R Rassekh, et al.

The Journal of Biological Chemistry|June 26, 2001

Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1R R Singaraja, V Bocher, E R James, et al.

The Journal of Clinical Investigation|November 22, 2000

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotesS M Clee, J J Kastelein, M van Dam, et al.

Neuron|July 13, 1999

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegenerationJ G Hodgson, N Agopyan, C A Gutekunst, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997

Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase geneE Ehrenborg, S M Clee, S N Pimstone, et al.

Cell Death and Differentiation|January 10, 2004

Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's diseaseE Hermel, J Gafni, S S Propp, et al.

Pageof 34